What is it about?
Evidence-based review of this drug for formulary evaluation
Featured Image
Why is it important?
treatment of opioid-induced constipation (OIC) in adults with chronic noncancer pain
Perspectives
Overview of the evidence regarding this drug at the time of FDA approval
Danial Baker
Washington State University
Read the Original
This page is a summary of: Formulary Drug Review: Naldemedine, Hospital Pharmacy, July 2017, SAGE Publications,
DOI: 10.1177/0018578717724805.
You can read the full text:
Contributors
The following have contributed to this page
